Tumor LINE-1 Methylation Level and Microsatellite Instability in Relation to Colorectal Cancer Prognosis
Open Access
- 4 September 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 106 (9)
- https://doi.org/10.1093/jnci/dju195
Abstract
Hypomethylation in long interspersed nucleotide element-1 (LINE-1) and high-degree microsatellite instability (MSI-high) in colorectal cancer (CRC) have been associated with inferior and superior survival, respectively; however, it remains uncertain whether the prognostic association of LINE-1 hypomethylation differs by MSI status. We hypothesized that the adverse prognostic association of LINE-1 hypomethylation might be stronger in MSI-high CRCs than in microsatellite stable (MSS) CRCs. Utilizing 1211 CRCs in the Nurses’ Health Study and the Health Professionals Follow-up Study, we examined patient survival according to LINE-1 hypomethylation status in strata of MSI status. A Cox proportional hazards model was used to compute multivariable CRC-specific mortality hazard ratios (HRs) for a 10% decrease in LINE-1 methylation level (range = 23.1–93.1%), adjusting for potential confounders, including CpG island methylator phenotype, and KRAS, BRAF, and PIK3CA mutations. Statistical tests (log-rank test, chi-square test, and likelihood ratio test) were two-sided. In MSI-high cancers, the association of LINE-1 hypomethylation with higher mortality (HR = 2.45, 95% confidence interval [CI] = 1.64 to 3.66, P < .001) was stronger than that in MSS cancers (HR = 1.10, 95% CI = 0.98 to 1.24, P = .11) (Pinteraction < .001, between LINE-1 and MSI statuses). In MSI-high cases with CRC family history, the association of LINE-1 hypomethylation with higher mortality (HR = 5.13, 95% CI = 1.99 to 13.2; P < .001) was stronger than that in MSI-high cases without CRC family history (HR = 1.62, 95% CI = 0.89 to 2.94, P = .11) (Pinteraction = .02, between LINE-1 and CRC family history statuses). The association of LINE-1 hypomethylation with inferior survival is stronger in MSI-high CRCs than in MSS CRCs. Tumor LINE-1 methylation level may be a useful prognostic biomarker to identify aggressive carcinomas among MSI-high CRCs.Keywords
This publication has 60 references indexed in Scilit:
- Epigenetics and Colorectal Cancer PathogenesisCancers, 2013
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- Increased methylation variation in epigenetic domains across cancer typesNature Genetics, 2011
- Long interspersed nuclear element-1 hypomethylation in cancer: biology and clinical applicationsClinical Epigenetics, 2011
- Improved measurement of LINE-1 sequence methylation for cancer detectionClinica Chimica Acta; International Journal of Clinical Chemistry, 2011
- DNA methylation predicts recurrence from resected stage III proximal colon cancerCancer, 2010
- Tumour‐infiltrating T‐cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature reviewThe Journal of Pathology, 2010
- Loss of epigenetic silencing in tumors preferentially affects primate-specific retroelementsGene, 2009
- LINE‐1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancerInternational Journal of Cancer, 2008
- MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon AdenocarcinomaJAMA, 2008